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groups II (55 %), III (65 %). The changes could be related to primary 
angioplasty, systematic since 2000.
Conclusions — Induction of ventricular  utter or  brillation is 
actually rarer than in years 1985/2000. The decrease corresponded 
with the development of primary angioplasty and revascularization. 
The induction of monomorphic VT < 270 b/min has not changed 
although a lower LVEF in patients studied since 2000.
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Nav1.5 is the voltage-gated sodium channel that initiates the 
cardiac action potential. A precise regulation and localisation of 
Nav1.5 channels in cardiomyocytes is thus necessary for correct 
heart function. The three last amino-acids of Nav1.5 (SIV) 
constitute a PDZ-domain binding motif known to interact with the 
syntrophin-dystrophin complex and PDZ domains found in proteins 
of the MAGUK family. Among their multiple roles, MAGUK proteins 
can cluster proteins and localize them at the plasma membrane.
We investigated the interaction between SAP97, one cardiac 
MAGUK protein, and Nav1.5. We postulated that this interaction 
may be implicated in correct localisation, anchoring, turn-over 
and/or regulation of Nav1.5 biophysical properties.
Pull-down experiments performed with Nav1.5 C-terminus fusion 
proteins and human or mouse heart protein extracts revealed that 
the association between SAP97 and Nav1.5 depends on the PDZ-
domain binding motif of Nav1.5. This interaction was speci c for 
SAP97 and Nav1.5 as no pull-down could be detected with PSD95 
or ZO-1, two MAGUK proteins also expressed in human heart. The 
functional consequences of this interaction were studied via patch-
clamp experiments. Silencing of SAP97 reduced the whole-cell 
sodium current measured in HEK293 cells stably expressing Nav1.5 
channels without decreasing the total protein amount. In control 
or silenced HEK293 cells, sodium current produced by Nav1.5 δSIV 
channels was reduced compared to WT. Immunostainings on frozen 
mouse heart slices demonstrated the colocalisation of Nav1.5 
and dystrophin speci cally at lateral membranes, but not at the 
intercalated discs. The possible colocalisation of Nav1.5 and SAP97 
at the level of intercalated disks is currently investigated. This 
would support the hypothesis of the presence of two pools of Nav1.5 
channels: one targeted at lateral membranes by the syntrophin-
dystrophin complex, and another one targeted at intercalated discs 
by SAP97.
These  ndings strongly support the existence of an interaction 
between Nav1.5 and SAP97 in cardiac tissue. This interaction also 
depends on the presence of Nav1.5 PDZ-domain binding motif and 
may play a role in determining the channel density at the plasma 
membrane. Additional biochemistry, cytochemistry and biophysical 
experiments will allow us to further address this question.
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Calcium entry into excitable cells can be regulated by controlling both 
the activity of calcium channels and the amount of channels available 
at the plasma membrane. Little is known about their internalisation 
and degradation. One post-translational modi cation shown to 
be involved in membrane protein internalisation and subsequent 
degradation is the attachment of ubiquitin moieties by ubiquitin-
ligases. Previously, it has been shown that cardiac ion channels such 
as Nav1.5 and KCNQ1 are down-regulated by ubiquitin-ligases of the 
Nedd4 family. These regulations involve the interaction between the 
PY motif of the target channels and the WW motif of the ubiquitin-
ligases. Despite the absence of such PY motif in the cardiac voltage-
gated calcium channel Cav1.2, we investigated whether this channel 
could by regulated in the same manner than other cardiac channels as 
previously described.
We co-expressed, in HEK293 cells, L-type calcium channels and its 
two regulatory subunits Cavbeta and Cavalpha2delta1 together 
with ubiquitin-ligases, and examined by voltage-clamp whole-cell 
recordings the calcium current. We next determined by western 
blot and surface biotinylation assays the availability of the different 
subunits of calcium channels in total HEK293 lysates, and at the 
cell surface. Levels of ubiquitylation of the different subunits were 
assessed by pull-down GST-S5A and immunoprecipitation of Cav1.2 
and its subunits.
We found that co-expressing the ubiquitin-ligase Nedd4-1 signi cantly 
reduced Cav currents, and decreased Cavalpha and its subunit protein 
levels. This effect was Nedd4-1 speci c since none of the other 
members of the Nedd4 family we tested produced a similar effect. 
We also found that the effect of Nedd4-1 was dependent on the co-
expression of the Cavbeta subunit. No Nedd4-1-dependent increase in 
ubiquitylation of the Cavalpha protein was found ; and unexpectedly, 
the two regulating subunits Cavbeta and Cavalpha2delta1 were 
detected to be deubiquitylated upon Nedd4-1 co-expression.
Our data suggest that Nedd4-1 regulates the expression of Cav channels 
and its subunits by Nedd4-1 via an indirect mechanism constituting a 
new regulatory pathway to be determined. Further experiments will 
focus on the role of adrenergic receptors known to be ubiquitylated 
by Nedd4 and to bind to Cav1.2.
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The prognosis of ventricular tachycardia (VT) is related to the 
presence of heart disease (HD). VT in patients without HD is 
considered as benign. However some sudden deaths were reported. 
The development of new methods as cardiac MRI has permitted 
to detect HD in some patients. The purpose of the study was to 
evaluate the incidence and prognosis of patients recruited since 30 
years for VT and without apparent HD with conventional methods.
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Population — 806 patients were admitted for sustained VT between 
1978 and 2008.
Methods — The following studies were performed: recording of 
ECG, signal averaged ECG, Holter monitoring, exercise testing 
(when possible), echocardiography, right angiography in patients 
with right VT, coronary angiography in patients older than 40 years 
and electrophysiological study.
Results — 74 patients (9 %), aged from 11 to 75 years (mean 46±18), 
45 men, 29 women had normal echocardiogram and hemodynamic 
study. Right ventricular out ow tract (RVOT) VT was noted in 42 
patients, verapamil-sensitive VT in 23 ; VT’s were right and left in 3 
patients, related to a bundle branch reentry in 1, of undetermined 
origin in 4 patients. VT developed at exercise testing in 15 patients 
and was inducible or occurred with isoproterenol in 54 patients 
(73 %). Erroneous diagnosis of supraventricular tachycardia with 
aberrancy was initially made in 5 patients. Beta blockers and/or 
antiarrhythmic drugs were initially prescribed. De brillator was 
implanted in one patient with syncopal RVOT-VT and 2 for a false 
diagnosis of right ventricle dysplasia made in 2002 at beginning of 
MRI. Catheter ablation for recurrent VT was performed in 3 patients 
with failure in one and in 1 patient for its job. Three patients were 
lost of view during follow—up (mean 11.5±6.6 years); remaining 
patients, but one are alive without recurrent VT and without 
drugs in half of them ; 1 patient died from non cardiac cause. One 
patient developed dilated cardiomyopathy ; 2 had permanent atrial 
 brillation.
Conclusions — VT in patients without apparent HD after conventional 
studies (echocardiography, hemodynamic study) represented 9 % of 
VT and required rarely a non medical treatment.
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Free fatty acids are the primary substrate used by the heart to generate 
cellular ATP. Carnitine, acylcarnitine and carnitine-transferase 
are essential for normal metabolism of long-chain fatty acids in 
heart. Some of the arrhythmias observed following an ischaemia 
are attributed to an accumulation of long-chain acylcarnitine into 
ad out the cells. It has also been observed that a de ciency in a 
carnitine transporter, OCTN2, normally found in heart, muscle and 
kidney, leads to a reduced plasma carnitine and acylcarnitine level. 
Such pathology was associated with the occurrence of ventricular 
 brillation and eventually to sudden death. All these data suggest 
that acyl-carnitine (Acyl-CARs) can regulate ion channels.
We studied the effects of different acyl-CARs at different 
concentrations on the hERG channel activity (IhERG) which is known 
to participate to lethal arrhythmias.
HEK293 cells stably expressing hERG were studied in patch clamp. 
Acyl-CAR derivatives from medium — (C8 and C10) and long-chain 
(C16 and C18:1) fatty acids were applied intra- and extracellularly 
at different concentrations.
C8-CAR and C10-CAR had no effect at 3 m and 30 m whether they 
are applied intra- or extracellularly. C16-CAR and C18-CAR had no 
effect on the current when applied intracellularly. Extracellularly, 
3 m C16-CAR or C18-CAR induced an increase of the current 
amplitude associated with different effects on the activation and 
availability properties. At this concentration, the long-chain acyl-
CAR induced also a speeding of deactivation kinetic.
Long-chain acyl-CARs, but not medium-chain, regulate extracellularly 
IhERG. When their level varies during diseases like primary systemic 
carnitine de ciency or ischaemia, there must be an impact on the 
action potential which can explain some of the cardiac arrhythmias 
observed.
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Rationnel — La maladie de Steinert (DM1) est une maladie 
systémique associée à un risque élevé de mort subite en rapport 
avec des troubles conductifs et des arythmies ventriculaires. Le 
mécanisme de ces morts subites n’est pas connu. Notre objectif 
était de déterminer si le syndrome de Brugada est impliqué dans 
ces complications.
Méthode — Nous avons analysé les électrocardiogrammes de 500 
patients atteints de maladie de Steinert. Les patients ayant un 
tracé ECG avec un Brugada de type 1 ont béné cié d’un séquençage 
du gène SCN5A et d’un bilan cardiaque comprenant un holter ECG, 
une échocardiographie et une exploration électrophysiologique.
Résultats — Un ECG avec un aspect de Brugada de type 1 a été 
identi é chez 7 patients, soit une prévalence 80 fois plus élevée 
que dans la population générale. Le séquençage de SCN5A était 
normal chez tous les patients. Un patient a fait une mort subite 
en rapport avec une  brillation ventriculaire et la stimulation 
ventriculaire programmée a déclenché des tachycardies 
ventriculaires polymorphes chez 5 patients.
Conlusion — La prévalence du syndrome de Brugada est plus élevée 
chez les patients DM1 que dans la population générale. Les patients 
présentant l’association de ces deux anomalies semblent exposés à 
un risque élevé d’arythmies ventriculaires sévères.
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Introduction — The major determinant of atrial  brillation initiation 
is focal  ring within the muscular portion of the pulmonary veins. 
We hypothesized that Interstitial Cajal cells, a known type of pace-
